WCN26-5025 MPO ANCA-ASSOCIATED VASCULITIS RELAPSE IN A LIVING KIDNEY DONOR PRECIPITATED BY HYDRALAZINE RE-INTRODUCTION

Read full text Summarise with VIRAT
Authors: Syed Zaidi, Matthew Beresford, Emma Wylie, Preetham Boddana, Arvind Singh
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Hydralazine is a widely used direct arteriolar vasodilator indicated for the treatment of hypertension and congestive cardiac failure. Hydralazine can cause autoimmune disease, including anti-neutrophil cytoplasmic antibody associated vasculitis and drug-induced lupus.

Fields of Study & Subjects

Vasculitis and related conditions Systemic Lupus Erythematosus Research Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103981–103981
Publication date
25 March 2026
Language
EN